
In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of the country.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3w22n8o
via
IFTTT
0 comments:
Post a Comment